½ÃÀ庸°í¼­
»óǰÄÚµå
1378572

¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, À̹ÌÁö À¯Çüº°, Áö¿ªº°

Neuroimaging Market, By Technology, By Application, By End-User, By Image Type, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´º·ÎÀ̹Ì¡ ½ÃÀå ±Ô¸ð´Â 2023³â 376¾ï 3,000·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 565¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 376¾ï 3,000¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018³â-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.00% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 565¾ï 8,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°(2030³â)
Neuroimaging Market-IMG1

´º·ÎÀ̹Ì¡Àº ³úÀÇ ±¸Á¶¿Í ±â´ÉÀ» ½Ã°¢È­ÇÏ´Â ÀÇ·á À̹ÌÁöÀÇ ÇÑ ºÐ¾ßÀÔ´Ï´Ù. ´Ù¾çÇÑ Áúº´°ú Àå¾ÖÀÇ ±Ùº»ÀûÀÎ ½Å°æÇÐÀû °úÁ¤°ú ÀÌ»ó¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ½Å°æ°úÇÐ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Àΰ£ÀÇ ³ú¸¦ ÀÌÇØÇÏ´Â µ¥ Å©°Ô ±â¿©ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

´º·ÎÀ̹Ì¡ ½ÃÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ù°, ½Å°æ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤È®ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ´º·ÎÀ̹Ì¡ ±â¼úÀÇ Ã¤ÅÃÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àڱ⠰ø¸í¿µ»ó¹ý(MRI), ¾çÀüÀÚ¹æ»ç´ÜÃþÃÔ¿µ¹ý(PET), ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ¹ý(CT) µîÀÇ ¿µ»ó±â¼úÀÇ Áøº¸·Î ³ú¿µ»ó ÇØ»óµµ¿Í Á¤¹Ðµµ°¡ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ½Å°æ ¿µ»ó Áø´Ü ÀåÄ¡ÀÇ °í°¡ÀÇ ºñ¿ë°ú ±×¿¡ µû¸¥ º¸¼ö ¹× ¿î¿ë ºñ¿ëÀÌ Æ¯È÷ °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ Á¢±Ù¼ºÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ CT ½ºÄµ¿¡¼­ Àü¸® ¹æ»ç¼± ³ëÃâ°ú °°Àº ƯÁ¤ ¿µ»ó Áø´Ü ±â¼úÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á´Â ½ÃÀå ¼ºÀå¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ±×·¡µµ ´º·ÎÀ̹Ì¡ ½ÃÀå¿¡´Â ¸î °¡Áö ±âȸ°¡ ÀÖ½À´Ï´Ù. ±â´ÉÀû ÀÚ±â°ø¸í À̹Ì¡(fMRI)°ú È®»ê ÅÙ¼­ À̹Ì¡(DTI)°ú °°Àº ÷´Ü À̹Ì¡ ±â¼ú °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡, °³ÀÎÈ­µÈ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ´º·ÎÀ̹Ì¡¿¡¼­ ÀΰøÁö´É(AI)ÀÇ ÅëÇÕÀº ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®À» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

  • Á¶»çÀÇ ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • È­»ó ±â¼úÀÇ Áøº¸
    • °í¾×ÀÇ ¼³ºñ ºñ¿ë
    • ¸ÂÃãÇü ÀÇ·á
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : ±â¼úº°(2023-2030³â)

  • Àڱ⠰ø¸í ¿µ»ó¹ý(MRI)
  • ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(CT)
  • ¾çÀüÀÚ ¹æÃâ ´ÜÃþ ÃÔ¿µ(PET)
  • ´ÜÀÏ ±¤ÀÚ ¹æ»ç¼± ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ(SPECT)
  • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó(fMRI)
  • È®»ê ÅÙ¼­ À̹Ì¡(DTI)
  • ³úÀÚµµ(MEG)
  • ³úÆÄ °Ë»ç(EEG)
  • ±âŸ

Á¦6Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : ¿ëµµº°(2023-2030³â)

  • ½Å°æÇÐÀû Àå¾Ö
  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • ÆÄŲ½¼º´
  • ´Ù¹ß¼º °æÈ­Áõ
  • °£Áú
  • ³úÁ¹Áß
  • ±âŸ
  • Á¤½ÅÀå¾Ö
  • Á¤½ÅºÐ¿­Áõ
  • ¾ç±Ø¼º Àå¾Ö
  • ¿ì¿ï
  • ºÒ¾ÈÀå¾Ö
  • ±âŸ
  • ¿Ü»ó¼º ³ú¼Õ»ó(TBI)
  • ³úÁ¾¾ç
  • ±âŸ

Á¦7Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2023-2030³â)

  • ¼Ò°³
  • º´¿ø ¹× Áø·á¼Ò
  • Á¶»ç±â°ü
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : À̹ÌÁö À¯Çüº°(2023-2030³â)

  • ¼Ò°³
  • ±¸Á¶ À̹Ì¡
  • ±â´ÉÀû À̹Ì¡
  • ÇÏÀ̺긮µå À̹Ì¡

Á¦9Àå ¼¼°è ´º·ÎÀ̹Ì¡ ½ÃÀå : Áö¿ªº°(2023-2030³â)

  • ¼Ò°³
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • GE Healthcare
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • Others

Á¦11Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
BJH 23.11.23

The Neuroimaging Market size is expected to reach US$ 56.58 Billion by 2030, from US$ 37.63 Billion in 2023, at a CAGR of 6% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 37.63 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.00% 2030 Value Projection: US$ 56.58 Bn
Figure 1. Global Neuroimaging Market Share (%), By Region, 2023
Neuroimaging Market - IMG1

Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underlie various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.

Market Dynamics:

The neuroimaging market is driven by several factors. Firstly, the growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.

However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Additionally, concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.

Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Moreover, the rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.

Key features of the study:

  • This report provides in-depth analysis of the global neuroimaging market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroimaging market

Detailed Segmentation:

  • By Technology:
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Functional Magnetic Resonance Imaging (fMRI)
    • Diffusion Tensor Imaging (DTI)
    • Magnetoencephalography (MEG)
    • Electroencephalography (EEG)
    • Others
  • By Application:
    • Neurological Disorders
    • Alzheimer's Disease
    • Parkinson's Disease
    • Multiple Sclerosis
    • Epilepsy
    • Stroke
    • Others
    • Psychiatric Disorders
    • Schizophrenia
    • Bipolar Disorder
    • Depression
    • Anxiety Disorders
    • Others
    • Traumatic Brain Injury (TBI)
    • Brain Tumors
    • Others
  • By End-User:
    • Hospitals and Clinics
    • Diagnostic Centers
    • Research Institutes
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • By Image Type:
    • Structural Imaging
    • Functional Imaging
    • Hybrid Imaging
  • Top companies in Neuroimaging Market
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Toshiba Medical Systems Corporation
    • Hitachi Healthcare
    • Canon Medical Systems Corporation
    • Mindray Medical International Limited
    • Esaote SpA
    • NeuroLogica Corporation
    • NeuroVive Pharmaceutical AG
    • Brainlab AG
    • Akili Interactive Labs Inc.
    • Brainomix Ltd.
    • Imaging Science International
    • Mevis Medical Solutions
    • NeuroVista
    • Neusoft Medical Systems
    • Positron Corporation
    • Shimadzu Corporation
    • Trifoil Imaging

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Image Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Advancements in Imaging Technology
    • High Equipment Costs
    • Personalized Medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Neuroimaging Market , By Technology, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Positron Emission Tomography (PET)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Single Photon Emission Computed Tomography (SPECT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Functional Magnetic Resonance Imaging (fMRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Diffusion Tensor Imaging (DTI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Magnetoencephalography (MEG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Electroencephalography (EEG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Neuroimaging Market , By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Epilepsy
  • Stroke
  • Others
  • Psychiatric Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Schizophrenia
  • Bipolar Disorder
  • Depression
  • Anxiety Disorders
  • Others
  • Traumatic Brain Injury (TBI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Brain Tumors
  • Others

7. Neuroimaging Market , By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Neuroimaging Market , By Image Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Structural Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Functional Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Hybrid Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Neuroimaging Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Toshiba Medical Systems Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hitachi Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Canon Medical Systems Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mindray Medical International Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Esaote SpA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NeuroLogica Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦